Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis

Marla C. Dubinsky , Lorna Charles , Krzysztof Selmaj , Giancarlo Comi , Anthony Krakovich , Melissa Rosen , C. Janneke van der Woude , Uma Mahadevan ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1093/ibd/izae011

Lay Summary This study evaluated pregnancy outcomes in patients with ulcerative colitis, Crohn’s disease, or multiple sclerosis and in healthy volunteers treated with ozanimod. There was no increased incidence of fetal abnormalities or adverse pregnancy outcomes with ozanimod exposure during early pregnancy.

Concepts

Medicine Ulcerative colitis Crohn's disease Disease Multiple sclerosis Pregnancy Internal medicine Crohn disease Gastroenterology Inflammatory bowel disease Dermatology Immunology Biology Genetics

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/ibd/izae011
PDF: https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izae011/56410260/izae011.pdf
OA Status: hybrid
Cited By: 25
References: 6
Related Works: 10
OpenAlex ID: https://openalex.org/W4391228078

All OpenAlex metadata

Raw OpenAlex JSON

No additional metadata available.

Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis Article Swipe

Related Topics To Compare & Contrast

Raw OpenAlex JSON